Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

JSE/LHC stock hub

JSE/LHC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

JSE/LHCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.8B

Johannesburg Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

JSE/LHC

In the news

Latest news · JSE/LHC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.7

P25 11.2P50 16.2P75 17.1

Trailing P/E4.2

P25 6.4P50 15.9P75 23.4

ROE-10.5

P25 -14P50 7.2P75 31.6

ROIC20.6

P25 9.2P50 15.3P75 38.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All JSE/LHC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

ZAR

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Africa
Country code	ZA
Employees	20,436
Employees Change	1,410%
Employees Change Percent	7.41
Enterprise value	ZAc 16.7B
Exchange	Johannesburg Stock Exchange
Financial currency	ZAR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	ZAE000145892
Last refreshed	2026-05-10
Market cap	ZAc 15.8B
Price	ZAc 1,101
Price currency	ZAc
Rev Per Employee	1,242,806.81x
Sector	Healthcare
Sic	8060
Symbol	jse/LHC
Website	https://www.lifehealthcare.co.za

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	23.97%
EV Earnings	4.41x
EV/EBIT	6.59x
EV/EBITDA	4.48x
EV/FCF	4.92x
EV/Sales	0.66x
FCF yield	21.5%
Forward P/E	8.73x
P/B ratio	1.3x
P/E ratio	4.17x
P/S ratio	0.62x
PE Ratio10 Y	19.65x
PE Ratio3 Y	8.26x
PE Ratio5 Y	21.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.95%
EBITDA Margin	13.95%
FCF margin	13.34%
Gross margin	27.79%
Gross Profit	ZAc 7.1B
Gross Profit Growth	-11.26%
Gross Profit Growth Q	4.72%
Gross Profit Growth3 Y	2.76%
Gross Profit Growth5 Y	0.69%
Net Income	ZAc 3.8B
Net Income Growth	-19.95%
Net Income Growth Q	358.13%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	5.51%
Net Income Growth5 Y	20.23%
Pretax Margin	-2.44%
Profit Margin	15.21%
Profit Per Employee	ZAc 184,821
Profitable Years	17
ROA	6.32
Roa5y	4.4
ROCE	13.56
ROE	-10.45
Roe5y	4.47
ROIC	20.58
Roic5y	8.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.55%
Cagr15y	5.76%
Cagr1y	-8.47%
Cagr3y	4.59%
Cagr5y	5.07%
Div CAGR10	8.89%
Div CAGR3	108.2%
Div CAGR5	70.57%
EPS Growth	-19.98
EPS Growth Q	387.4
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	5.93
EPS Growth5 Y	20.49
FCF Growth	-3.83%
FCF Growth Q	5.92%
FCF Growth3 Y	-7.93%
FCF Growth5 Y	3.13%
OCF Growth	4.28%
OCF Growth Q	11.62%
OCF Growth10 Y	0.88%
OCF Growth3 Y	-3.84%
OCF Growth5 Y	5.53%
Revenue Growth	6.06x
Revenue Growth Q	4.1x
Revenue Growth Years	0x
Revenue Growth3 Y	2.99x
Revenue Growth5 Y	5.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ZAc 1.02
Assets	ZAc 25.7B
Cash	ZAc 3.8B
Current Assets	ZAc 8.5B
Current Liabilities	ZAc 7B
Debt	ZAc 4B
Debt EBITDA	ZAc 1.06
Debt Equity	ZAc 0.33
Debt FCF	ZAc 1.17
Equity	ZAc 12.1B
Interest Coverage	6.96
Liabilities	ZAc 13.5B
Long Term Assets	ZAc 17.2B
Long Term Liabilities	ZAc 6.5B
Net Cash	ZAc -141M
Net Cash By Market Cap	ZAc -0.89
Net Debt EBITDA	ZAc 0.04
Net Debt Equity	ZAc 0.01
Net Debt FCF	ZAc 0.04
Tangible Book Value	ZAc 9B
Tangible Book Value Per Share	ZAc 6.32
WACC	5.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.2
Inventory Turnover	41.97
Net Working Capital	ZAc -2.2B
Quick ratio	1.03
Working Capital	ZAc 1.4B
Working Capital Turnover	ZAc 13.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.5%
Dividend Growth	-44.46%
Dividend Growth Years	0%
Dividend per share	ZAc 0.7
Dividend Years	5
Dividend Yield	6.36%
Ex Div Date	2025-12-17
Last Dividend	ZAc 0.35
Payout Ratio	135.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-14.46%
1Y total return	-8.46%
200-day SMA	1,199.8
3Y total return	14.43%
50-day SMA	1,178.8
50-day SMA vs 200-day SMA	50under200
5Y total return	28.07%
All Time High	4,781
All Time High Change	-76.97%
All Time High Date	2014-09-10
All Time Low	993
All Time Low Change	10.88%
All Time Low Date	2024-05-02
ATR	43.5
Beta	0.16
Beta1y	0.37
Beta2y	0.4
Ch YTD	-3.34
High	1,150
High52	1,533
High52 Date	2025-05-08
High52ch	-28.18%
Low	1,099
Low52	1,014
Low52 Date	2025-11-27
Low52ch	8.58%
Ma50ch	-6.6%
Price vs 200-day SMA	-8.23%
RSI	31.29
RSI Monthly	38.16
RSI Weekly	43.23
Sharpe ratio	-0.34x
Sortino ratio	-0.25
Total Return	6.85%
Tr YTD	-3.34
Tr15y	131.48%
Tr1m	-6.69%
Tr1w	-12.27%
Tr3m	0.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ZAc 2.5B
Operating Income Growth	-16.62
Operating Income Growth Q	6.36
Operating Income Growth3 Y	1.8
Operating Income Growth5 Y	2.03
Operating margin	9.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,331,673,348%
Net Borrowing	-519,000,000
Shares Insiders	0.4%
Shares Institutions	77.3%
Shares Out	1,431,029,162
Shares Qo Q	-0.56%
Shares Yo Y	-0.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ZAc 3B
Average Volume	3,101,222.5x
Bv Per Share	7.95
CAPEX	ZAc -1.6B
Ch10y	-69.37
Ch15y	-33.23
Ch1m	-6.69
Ch1w	-12.27
Ch1y	-27.61
Ch3m	0.46
Ch3y	-46.86
Ch5y	-42.51
Ch6m	-6.22
Change	-2.31%
Change From Open	-4.26
Close	1,127
Days Gap	2.04
Depreciation Amortization	1,015,000,000
Dollar Volume	2,041,596,411
Earnings Date	2026-05-28
EBIT	ZAc 2.5B
EBITDA	ZAc 3.5B
EPS	ZAc 2.63
F Score	7
FCF	ZAc 3.4B
FCF EV Yield	20.33x
FCF Per Share	ZAc 2.37
Financing CF	-6,888,000,000
Fiscal Year End	September
Founded	1,983
Goodwill	1,724,000,000
Graham Number	2244.71589
Graham Upside	103.9
Income Tax	ZAc 721M
Investing CF	3,872,000,000
Is Primary Listing	1
Last Earnings Date	2025-11-27
Last Report Date	2025-09-30
Lynch Fair Value	ZAc 5,339
Lynch Upside	384.9
Ma150	1,162
Ma150ch	-5.25%
Ma20	1,230.8
Ma20ch	-10.54%
Net CF	1,948,000,000
Next Earnings Date	2026-05-28
Open	1,150
P FCF Ratio	4.65
P OCF Ratio	3.14
Payment Date	2025-12-22
Position In Range	3.92
Ppne	11,301,000,000
Price Date	2026-05-08
Price EBITDA	ZAc 4.45
Ptbv Ratio	1.74
Relative Volume	0.6x
Revenue	25,398,000,000x
SBC By Revenue	1.39x
Share Based Comp	352,000,000
Tax By Revenue	2.84x
Tr6m	-3.23%
Volume	1,854,311
Z Score	2.25

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

JSE/LHC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+6.4%

$0.70 annual per share

Payout ratio

+135.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+70.6%

0 consecutive years of growth

Total shareholder yield

+6.9%

Next ex-dividend date: 2025-12-17

Performance

JSE/LHC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns JSE/LHC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+77.3%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.5%

Negative means the company is buying back shares.

Technical

JSE/LHC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.3

Neutral momentum band

Price vs 200-day MA

-8.2%

50/200-day relationship not available

Beta (5Y)

0.16

Less volatile than the market

Sharpe ratio

-0.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About JSE/LHC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current jse/LHC stock rating?

jse/LHC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full jse/LHC analysis?

The full report lives at /stocks/jse/LHC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for jse/LHC?

The latest report frames jse/LHC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the jse/LHC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.